Acumen Pharmaceuticals, Inc. (ABOS)

Market Closed

26 Oct, 08:00 PM

NASDAQ (NGS)

2. 28

+0.3

+15.1515%

After Hours

2. 39

+0.11 +4.8246%

122.22M Market Cap

- P/E Ratio

- Div Yield

101,077 Volume

- Eps

$ 1.98

Previous Close

Investors:

Day Range

1.98 2.41

Year Range

1.5 3.6

Want to track ABOS and more in your Portfolio? 🎯

Acumen Pharmaceuticals, Inc. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
BG Bart Gancher Intech Investment Management LLC	10,446	$23,921.34	$23,623.63	-$297.71	-1.24%
CD Charlie Durham Sterling Capital Management LLC	932	$2,134.28	$2,017.78	-$116.5	-5.46%
DRO Donal Reamonn O'Sullivan Brevan Howard Capital Management LP	15,385	$36,309	$31,616.17	-$4,692.83	-12.92%
RS Robert Sterner Rangeley Capital LLC	35,000	$82,600	$74,375	-$8,225	-9.96%
Joseph Castro Nuveen LLC	63,355	$145,082.95	$147,300.37	$2,217.42	1.53%
Taro Kuriyama Axq Capita LLP	24,426	$57,645.09	$49,218.39	-$8,426.7	-14.62%
Daniel Ronan Catalyst Financial Partners LLC	89,699	$431,452	$180,294.99	-$251,157.01	-58.21%
Hui Fai Tam Caitong International Asset Management Co. Ltd.	39	$89.31	$87.16	-$2.15	-2.41%
PIL PFG Investments LLC PFG Investments LLC	94,250	$212,142	$211,591.25	-$550.75	-0.26%
Christopher C. Powers Farther Finance Advisors, LLC	225	$287.56	$531	$243.44	84.66%
RJ Rebecca Judd Pathstone Holdings, LLC	859,110	$1.74M	$2M	$252,903.59	14.5%
Mark Schafer Police & Firemen's Retirement System of New Jersey	19,393	$44,409.97	$45,088.72	$678.75	1.53%
Clune & Associates Ltd. Clune & Associates Ltd.	16,500	$28,380	$31,845	$3,465	12.21%